Advertisement

Molecular Biology Reports

, Volume 46, Issue 1, pp 751–762 | Cite as

Sodium selenite protects from 3-nitropropionic acid-induced oxidative stress in cultured primary cortical neurons

  • Dirleise ColleEmail author
  • Danúbia Bonfanti Santos
  • Viviane de Souza
  • Mark William Lopes
  • Rodrigo Bainy Leal
  • Patricia de Souza Brocardo
  • Marcelo FarinaEmail author
Original Article
  • 48 Downloads

Abstract

Selenium (Se) is an essential trace element for humans; its intake is needed to allow the proper synthesis of 25 different selenoproteins that are necessary to the normal functioning of several organs, including the brain. Accordingly, decreased Se levels have been associated with neurological disorders. In the present study, we investigated the potential beneficial effects of Se, as sodium selenite, against 3-nitropropionic acid (3-NP)-induced oxidative stress in primary cultures of mouse cortical neurons. 3-NP treatment caused a significant decrease in cellular viability, which was accompanied by decreases in mitochondrial complex II activity and reduced glutathione (GSH) content, as well as increases in reactive oxygen species (ROS) generation and oxidized glutathione (GSSG) levels. Sodium selenite pretreatment (6 days) attenuated 3-NP-induced decrease in cell viability. In addition, sodium selenite pretreatment significantly protected against 3-NP-induced increase in ROS generation and decrease in GSH/GSSG ratio. Of note, sodium selenite pretreatment did not change 3-NP-induced decrease of mitochondrial complex II activity, suggesting that Se modulates secondary events resultant from 3-NP-induced mitochondrial dyshomeostasis. In addition, sodium selenite pretreatment significantly increased glutathione peroxidase (GPx) activity. Our data provide insights into the mechanism of protection by sodium selenite, which is related, at least in part, to GPx induction.

Keywords

3-Nitropropionic acid Sodium selenite Mitochondrial dysfunction Oxidative stress Glutathione peroxidase 1 

Notes

Acknowledgements

The financial supports by (i) Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), (ii) Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) and (iii) Fundação de Apoio à Pesquisa do Estado de Santa Catarina (FAPESC) are gratefully acknowledged. P.S.B. acknowledges the Science Without Borders Program. M.F. is a CNPq fellowship recipient.

Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All experimental protocols were approved by the local Animal Ethics Committee of Federal University of Santa Catarina, Brazil (ethical permission numbers: PP00817/CEUA/UFSC).

Research involving human participants

This article does not contain any studies with human participants performed by any of the authors.

Supplementary material

11033_2018_4531_MOESM1_ESM.tif (10.6 mb)
Supplementary fig. 1 Representative images of cortical neurons. Representative images of non-treated cortical neurons at DIV 3 (left panels; upper panel: 20x objective and lower panel: 40x objective) and at DIV 7 (right panels; upper panel: 20x objective and lower panel: 40x objective). The images were acquired using an Olympus IX83UC microscope connected to a capture system (CellSens Dimension 1.12). DIV: day in vitro (TIF 10898 KB)

References

  1. 1.
    Arun S, Liu L, Donmez G (2016) Mitochondrial biology and neurological diseases. Curr Neuropharmacol 14(2):143–154Google Scholar
  2. 2.
    Cabezas-Opazo FA, Vergara-Pulgar K, Perez MJ, Jara C, Osorio-Fuentealba C, Quintanilla RA (2015) Mitochondrial dysfunction contributes to the pathogenesis of Alzheimer’s disease. Oxid Med Cell Longev 2015:509654Google Scholar
  3. 3.
    Luo Y, Hoffer A, Hoffer B, Qi X (2015) Mitochondria: a therapeutic target for Parkinson’s disease? Int J Mol Sci 16(9):20704–20730Google Scholar
  4. 4.
    Guedes-Dias P, Pinho BR, Soares TR, de Proenca J, Duchen MR, Oliveira JM (2016) Mitochondrial dynamics and quality control in Huntington’s disease. Neurobiol Dis 90:51–57Google Scholar
  5. 5.
    Carmo C, Naia L, Lopes C, Rego AC (2018) Mitochondrial dysfunction in Huntington’s disease. Adv Exp Med Biol 1049:59–83Google Scholar
  6. 6.
    Mochel F, Haller RG (2011) Energy deficit in Huntington disease: why it matters. J Clin Investig 121(2):493–499Google Scholar
  7. 7.
    Oliveira JM (2010) Mitochondrial bioenergetics and dynamics in Huntington’s disease: tripartite synapses and selective striatal degeneration. J Bioenerg Biomembr 42(3):227–234Google Scholar
  8. 8.
    Roos RA (2010) Huntington’s disease: a clinical review. Orphanet J Rare Dis 5(1):40Google Scholar
  9. 9.
    Heinsen H, Strik M, Bauer M, Luther K, Ulmar G, Gangnus D, Jungkunz G, Eisenmenger W, Gotz M (1994) Cortical and striatal neurone number in Huntington’s disease. Acta Neuropathol 88(4):320–333Google Scholar
  10. 10.
    Reiner A, Albin RL, Anderson KD, D’Amato CJ, Penney JB, Young AB (1988) Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci USA 85(15):5733–5737Google Scholar
  11. 11.
    Tunez I, Tasset I, Perez-De La Cruz V, Santamaria A (2010) 3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington’s disease: past, present and future. Molecules 15(2):878–916Google Scholar
  12. 12.
    Hariharan A, Shetty S, Shirole T, Jagtap AG (2014) Potential of protease inhibitor in 3-nitropropionic acid induced Huntington’s disease like symptoms: mitochondrial dysfunction and neurodegeneration. Neurotoxicology 45:139–148Google Scholar
  13. 13.
    Mehrotra A, Kanwal A, Banerjee SK, Sandhir R (2015) Mitochondrial modulators in experimental Huntington’s disease: reversal of mitochondrial dysfunctions and cognitive deficits. Neurobiol Aging 36(6):2186–2200Google Scholar
  14. 14.
    Dhadde SB, Nagakannan P, Roopesh M, Anand Kumar SR, Thippeswamy BS, Veerapur VP, Badami S (2016) Effect of embelin against 3-nitropropionic acid-induced Huntington’s disease in rats. Biomed Pharmacother 77:52–58Google Scholar
  15. 15.
    Kumar P, Kalonia H, Kumar A (2010) Huntington’s disease: pathogenesis to animal models. Pharmacol Rep 62(1):1–14Google Scholar
  16. 16.
    McCubrey JA, Lahair MM, Franklin RA (2006) Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid Redox Signal 8(9–10):1775–1789Google Scholar
  17. 17.
    Turjanski AG, Vaque JP, Gutkind JS (2007) MAP kinases and the control of nuclear events. Oncogene 26(22):3240–3253Google Scholar
  18. 18.
    Arthur JS, Ley SC (2013) Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol 13(9):679–692Google Scholar
  19. 19.
    Kim EK, Choi EJ (2010) Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta 1802(4):396–405Google Scholar
  20. 20.
    Garcia M, Vanhoutte P, Pages C, Besson MJ, Brouillet E, Caboche J (2002) The mitochondrial toxin 3-nitropropionic acid induces striatal neurodegeneration via a c-Jun N-terminal kinase/c-Jun module. J Neurosci 22(6):2174–2184Google Scholar
  21. 21.
    Choi YJ, Kim NH, Lim MS, Lee HJ, Kim SS, Chun W (2014) Geldanamycin attenuates 3-nitropropionic acidinduced apoptosis and JNK activation through the expression of HSP 70 in striatal cells. Int J Mol Med 34(1):24–34Google Scholar
  22. 22.
    Zhang S, Rocourt C, Cheng WH (2010) Selenoproteins and the aging brain. Mech Ageing Dev 131(4):253–260Google Scholar
  23. 23.
    Cardoso BR, Ong TP, Jacob-Filho W, Jaluul O, Freitas MI, Cozzolino SM (2010) Nutritional status of selenium in Alzheimer’s disease patients. Br J Nutr 103(6):803–806Google Scholar
  24. 24.
    Haratake M, Yoshida S, Mandai M, Fuchigami T, Nakayama M (2013) Elevated amyloid-beta plaque deposition in dietary selenium-deficient Tg2576 transgenic mice. Metallomics 5(5):479–483Google Scholar
  25. 25.
    Solovyev ND (2015) Importance of selenium and selenoprotein for brain function: from antioxidant protection to neuronal signalling. J Inorg Biochem 153:1–12Google Scholar
  26. 26.
    Salim S (2017) Oxidative stress and the central nervous system. J Pharmacol Exp Ther 360(1):201–205Google Scholar
  27. 27.
    Cardoso BR, Roberts BR, Bush AI, Hare DJ (2015) Selenium, selenoproteins and neurodegenerative diseases. Metallomics 7(8):1213–1228Google Scholar
  28. 28.
    Bortolatto CF, Jesse CR, Wilhelm EA, Chagas PM, Nogueira CW (2013) Organoselenium bis selenide attenuates 3-nitropropionic acid-induced neurotoxicity in rats. Neurotox Res 23(3):214–224Google Scholar
  29. 29.
    Lu Z, Marks E, Chen J, Moline J, Barrows L, Raisbeck M, Volitakis I, Cherny RA, Chopra V, Bush AI, Hersch S, Fox JH (2014) Altered selenium status in Huntington’s disease: neuroprotection by selenite in the N171-82Q mouse model. Neurobiol Dis 71:34–42Google Scholar
  30. 30.
    Briz V, Galofre M, Sunol C (2010) Reduction of glutamatergic neurotransmission by prolonged exposure to dieldrin involves NMDA receptor internalization and metabotropic glutamate receptor 5 downregulation. Toxicol Sci 113(1):138–149Google Scholar
  31. 31.
    Regueiro J, Olguin N, Simal-Gandara J, Sunol C (2015) Toxicity evaluation of new agricultural fungicides in primary cultured cortical neurons. Environ Res 140:37–44Google Scholar
  32. 32.
    Solà C, Cristòfol R, Suñol C, Sanfeliu C (2011) Primary cultures for neurotoxicity testing. In: Aschner M, Suñol C, Bal-Price A (eds) Cell culture techniques. Humana Press, New York, pp 87–103Google Scholar
  33. 33.
    Romanowska M, Kikawa KD, Fields JR, Maciag A, North SL, Shiao YH, Kasprzak KS, Anderson LM (2007) Effects of selenium supplementation on expression of glutathione peroxidase isoforms in cultured human lung adenocarcinoma cell lines. Lung Cancer 55(1):35–42Google Scholar
  34. 34.
    Akashiba H, Ikegaya Y, Nishiyama N, Matsuki N (2008) Differential involvement of cell cycle reactivation between striatal and cortical neurons in cell death induced by 3-nitropropionic acid. J Biol Chem 283(10):6594–6606Google Scholar
  35. 35.
    Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(1–2):55–63Google Scholar
  36. 36.
    Colle D, Santos DB, Hartwig JM, Godoi M, Braga AL, Farina M (2013) Succinobucol versus probucol: higher efficiency of succinobucol in mitigating 3-NP-induced brain mitochondrial dysfunction and oxidative stress in vitro. Mitochondrion 13(2):125–133Google Scholar
  37. 37.
    Perez-De La Cruz V, Elinos-Calderon D, Robledo-Arratia Y, Medina-Campos ON, Pedraza-Chaverri J, Ali SF, Santamaria A (2009) Targeting oxidative/nitrergic stress ameliorates motor impairment, and attenuates synaptic mitochondrial dysfunction and lipid peroxidation in two models of Huntington’s disease. Behav Brain Res 199(2):210–217Google Scholar
  38. 38.
    Rosa R, Sanfeliu C, Sunol C, Pomes A, Rodriguez-Farre E, Schousboe A, Frandsen A (1997) The mechanism for hexachlorocyclohexane-induced cytotoxicity and changes in intracellular Ca2 + homeostasis in cultured cerebellar granule neurons is different for the gamma- and delta-isomers. Toxicol Appl Pharmacol 142(1):31–39Google Scholar
  39. 39.
    Farina M, Campos F, Vendrell I, Berenguer J, Barzi M, Pons S, Sunol C (2009) Probucol increases glutathione peroxidase-1 activity and displays long-lasting protection against methylmercury toxicity in cerebellar granule cells. Toxicol Sci 112(2):416–426Google Scholar
  40. 40.
    Ali SF, LeBel CP, Bondy SC (1992) Reactive oxygen species formation as a biomarker of methylmercury and trimethyltin neurotoxicity. Neurotoxicology 13(3):637–648Google Scholar
  41. 41.
    Fischer JC, Ruitenbeek W, Berden JA, Trijbels JM, Veerkamp JH, Stadhouders AM, Sengers RC, Janssen AJ (1985) Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin Chim Acta 153(1):23–36Google Scholar
  42. 42.
    Wendel A (1981) Glutathione peroxidase. Methods Enzymol 77:325–333Google Scholar
  43. 43.
    Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193(1):265–275Google Scholar
  44. 44.
    Yoo MH, Gu X, Xu XM, Kim JY, Carlson BA, Patterson AD, Cai H, Gladyshev VN, Hatfield DL (2010) Delineating the role of glutathione peroxidase 4 in protecting cells against lipid hydroperoxide damage and in Alzheimer’s disease. Antioxid Redox Signal 12(7):819–827Google Scholar
  45. 45.
    Mason RP, Casu M, Butler N, Breda C, Campesan S, Clapp J, Green EW, Dhulkhed D, Kyriacou CP, Giorgini F (2013) Glutathione peroxidase activity is neuroprotective in models of Huntington’s disease. Nat Genet 45(10):1249–1254Google Scholar
  46. 46.
    Dringen R, Pawlowski PG, Hirrlinger J (2005) Peroxide detoxification by brain cells. J Neurosci Res 79(1–2):157–165Google Scholar
  47. 47.
    Liddell JR, Dringen R, Crack PJ, Robinson SR (2006) Glutathione peroxidase 1 and a high cellular glutathione concentration are essential for effective organic hydroperoxide detoxification in astrocytes. Glia 54(8):873–879Google Scholar
  48. 48.
    Kim EK, Choi EJ (2015) Compromised MAPK signaling in human diseases: an update. Arch Toxicol 89(6):867–882Google Scholar
  49. 49.
    Jamwal S, Kumar P (2017) L-theanine, a component of green tea prevents 3-nitropropionic acid (3-NP)-induced striatal TOXICITY by modulating nitric oxide pathway. Mol Neurobiol 54(3):2327–2337Google Scholar
  50. 50.
    Lee WT, Yin HS, Shen YZ (2002) The mechanisms of neuronal death produced by mitochondrial toxin 3-nitropropionic acid: the roles of N-methyl-D-aspartate glutamate receptors and mitochondrial calcium overload. Neuroscience 112(3):707–716Google Scholar
  51. 51.
    Huang LS, Sun G, Cobessi D, Wang AC, Shen JT, Tung EY, Anderson VE, Berry EA (2006) 3-nitropropionic acid is a suicide inhibitor of mitochondrial respiration that, upon oxidation by complex II, forms a covalent adduct with a catalytic base arginine in the active site of the enzyme. J Biol Chem 281(9):5965–5972Google Scholar
  52. 52.
    Coles CJ, Edmondson DE, Singer TP (1979) Inactivation of succinate dehydrogenase by 3-nitropropionate. J Biol Chem 254(12):5161–5167Google Scholar
  53. 53.
    Liot G, Bossy B, Lubitz S, Kushnareva Y, Sejbuk N, Bossy-Wetzel E (2009) Complex II inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death via an NMDA- and ROS-dependent pathway. Cell Death Differ 16(6):899–909Google Scholar
  54. 54.
    Tunez I, Sanchez-Lopez F, Aguera E, Fernandez-Bolanos R, Sanchez FM, Tasset-Cuevas I (2011) Important role of oxidative stress biomarkers in Huntington’s disease. J Med Chem 54(15):5602–5606Google Scholar
  55. 55.
    Hazane-Puch F, Champelovier P, Arnaud J, Trocme C, Garrel C, Faure P, Laporte F (2014) Six-day selenium supplementation led to either UVA-photoprotection or toxic effects in human fibroblasts depending on the chemical form and dose of Se. Metallomics 6(9):1683–1692Google Scholar
  56. 56.
    Song E, Su C, Fu J, Xia X, Yang S, Xiao C, Lu B, Chen H, Sun Z, Wu S, Song Y (2014) Selenium supplementation shows protective effects against patulin-induced brain damage in mice via increases in GSH-related enzyme activity and expression. Life Sci 109(1):37–43Google Scholar
  57. 57.
    Santamaria A, Salvatierra-Sanchez R, Vazquez-Roman B, Santiago-Lopez D, Villeda-Hernandez J, Galvan-Arzate S, Jimenez-Capdeville ME, Ali SF (2003) Protective effects of the antioxidant selenium on quinolinic acid-induced neurotoxicity in rats: in vitro and in vivo studies. J Neurochem 86(2):479–488Google Scholar
  58. 58.
    Wu X, Wei C, Pan C, Duan Y, Huang K (2010) Regulation of expression and activity of selenoenzymes by different forms and concentrations of selenium in primary cultured chicken hepatocytes. Br J Nutr 104(11):1605–1612Google Scholar
  59. 59.
    Wajner SM, Rohenkohl HC, Serrano T, Maia AL (2015) Sodium selenite supplementation does not fully restore oxidative stress-induced deiodinase dysfunction: implications for the nonthyroidal illness syndrome. Redox Biol 6:436–445Google Scholar
  60. 60.
    Sepasi Tehrani H, Moosavi-Movahedi AA (2018) Catalase and its mysteries. Prog Biophys Mol Biol.  https://doi.org/10.1016/j.pbiomolbio.2018.03.001 Google Scholar
  61. 61.
    Brigelius-Flohe R, Maiorino M (2013) Glutathione peroxidases. Biochim Biophys Acta 1830(5):3289–3303Google Scholar
  62. 62.
    Flohé L (ed) (1989) The selenoprotein glutathione peroxidase. glutathione: chemical, biochemical, and medical aspects. Wiley, HobokenGoogle Scholar
  63. 63.
    Bensadoun JC, Mirochnitchenko O, Inouye M, Aebischer P, Zurn AD (1998) Attenuation of 6-OHDA-induced neurotoxicity in glutathione peroxidase transgenic mice. Eur J Neurosci 10(10):3231–3236Google Scholar
  64. 64.
    Crack PJ, Cimdins K, Ali U, Hertzog PJ, Iannello RC (2006) Lack of glutathione peroxidase-1 exacerbates abeta-mediated neurotoxicity in cortical neurons. J Neural Transm 113(5):645–657Google Scholar
  65. 65.
    Crack PJ, Taylor JM, Ali U, Mansell A, Hertzog PJ (2006) Potential contribution of NF-kappaB in neuronal cell death in the glutathione peroxidase-1 knockout mouse in response to ischemia-reperfusion injury. Stroke 37(6):1533–1538Google Scholar
  66. 66.
    Klivenyi P, Andreassen OA, Ferrante RJ, Dedeoglu A, Mueller G, Lancelot E, Bogdanov M, Andersen JK, Jiang D, Beal MF (2000) Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. J Neurosci 20(1):1–7Google Scholar
  67. 67.
    Mandavilli BS, Boldogh I, Van Houten B (2005) 3-nitropropionic acid-induced hydrogen peroxide, mitochondrial DNA damage, and cell death are attenuated by Bcl-2 overexpression in PC12 cells. Mol Brain Res 133(2):215–223Google Scholar
  68. 68.
    Yeo JE, Kim JH, Kang SK (2008) Selenium attenuates ROS-mediated apoptotic cell death of injured spinal cord through prevention of mitochondria dysfunction; in vitro and in vivo study. Cell Physiol Biochem 21(1–3):225–238Google Scholar
  69. 69.
    Barayuga SM, Pang X, Andres MA, Panee J, Bellinger FP (2013) Methamphetamine decreases levels of glutathione peroxidases 1 and 4 in SH-SY5Y neuronal cells. Neurotoxicology 37:240–246Google Scholar
  70. 70.
    Khera A, Vanderlelie JJ, Holland O, Perkins AV (2017) Overexpression of endogenous anti-oxidants with selenium supplementation protects trophoblast cells from reactive oxygen species-induced apoptosis in a Bcl-2-dependent manner. Biol Trace Elem Res 177(2):394–403Google Scholar
  71. 71.
    Miller S, Walker SW, Arthur JR, Nicol F, Pickard K, Lewin MH, Howie AF, Beckett GJ (2001) Selenite protects human endothelial cells from oxidative damage and induces thioredoxin reductase. Clin Sci 100(5):543–550Google Scholar
  72. 72.
    Kipp AP, Frombach J, Deubel S, Brigelius-Flohe R (2013) Selenoprotein W as biomarker for the efficacy of selenium compounds to act as source for selenoprotein biosynthesis. Methods Enzymol 527:87–112Google Scholar
  73. 73.
    Raman AV, Pitts MW, Seyedali A, Hashimoto AC, Bellinger FP, Berry MJ (2013) Selenoprotein W expression and regulation in mouse brain and neurons. Brain Behav 3(5):562–574Google Scholar
  74. 74.
    Takahashi K, Suzuki N, Ogra Y (2017) Bioavailability comparison of nine bioselenocompounds in vitro and in vivo. Int J Mol Sci 18(3):E506Google Scholar
  75. 75.
    Allingstrup M, Afshari A (2015) Selenium supplementation for critically ill adults. Cochrane Database Syst Rev  https://doi.org/10.1002/14651858 Google Scholar
  76. 76.
    Sakr Y, Maia VP, Santos C, Stracke J, Zeidan M, Bayer O, Reinhart K (2014) Adjuvant selenium supplementation in the form of sodium selenite in postoperative critically ill patients with severe sepsis. Crit Care 18(2):R68Google Scholar
  77. 77.
    Danielsson BR, Danielson M, Khayat A, Wide M (1990) Comparative embryotoxicity of selenite and selenate: uptake in murine embryonal and fetal tissues and effects on blastocysts and embryonic cells in vitro. Toxicology 63(2):123–136Google Scholar
  78. 78.
    Biswas S, Talukder G, Sharma A (1999) Comparison of clastogenic effects of inorganic selenium salts in mice in vivo as related to concentrations and duration of exposure. Biometals 12(4):361–368Google Scholar
  79. 79.
    Kobayashi Y, Ogra Y, Suzuki KT (2001) Speciation and metabolism of selenium injected with 82Se-enriched selenite and selenate in rats. J Chromatogr B 760(1):73–81Google Scholar
  80. 80.
    Roman M, Jitaru P, Barbante C (2014) Selenium biochemistry and its role for human health. Metallomics 6(1):25–54Google Scholar
  81. 81.
    Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22(2):153–183Google Scholar
  82. 82.
    Chu CT, Levinthal DJ, Kulich SM, Chalovich EM, DeFranco DB (2004) Oxidative neuronal injury. The dark side of ERK1/2. Eur J Biochem 271(11):2060–2066Google Scholar
  83. 83.
    Hetman M, Gozdz A (2004) Role of extracellular signal regulated kinases 1 and 2 in neuronal survival. Eur J Biochem 271(11):2050–2055Google Scholar
  84. 84.
    Tung YT, Hsu WM, Wang BJ, Wu SY, Yen CT, Hu MK, Liao YF (2008) Sodium selenite inhibits gamma-secretase activity through activation of ERK. Neurosci Lett 440(1):38–43Google Scholar
  85. 85.
    Wu CL, Yin JH, Hwang CS, Chen SD, Yang DY, Yang DI (2012) c-Jun-dependent sulfiredoxin induction mediates BDNF protection against mitochondrial inhibition in rat cortical neurons. Neurobiol Dis 46(2):450–462Google Scholar

Copyright information

© Springer Nature B.V. 2018

Authors and Affiliations

  1. 1.Departamento de Bioquímica, Centro de Ciências BiológicasUniversidade Federal de Santa CatarinaFlorianópolisBrazil
  2. 2.Departamento de Análises Clínicas, Centro de Ciências da SaúdeUniversidade Federal de Santa CatarinaFlorianópolisBrazil
  3. 3.Departamento de Ciências Morfológicas, Centro de Ciências BiológicasUniversidade Federal de Santa CatarinaFlorianópolisBrazil

Personalised recommendations